Multi-Domain Programming & Usage Guidance

1. Regenerative Pain Control

• Using clinically studied electrotherapy specifications derived from the Jstim – Joint Stimulator; low-level frequencies are coupled with high volt stimulation set to a monophasic waveform. Such specifications have been studied to promote cartilage regeneration in the joint.
• Interferential therapy (IFT) targets chronic intractable back pain by using intersecting medium-frequency electrical currents to penetrate deep tissue, block pain signals, reduce inflammation, and improve muscle relaxation. This technique is especially effective for pain that has not responded to other treatments due to its ability to stimulate targeted nerves and muscles beneath the skin with minimal discomfort.
• Target Indications: Treat degenerative joint conditions such as Osteoarthritis (OA) and Rheumatoid Arthritis (RA) of the knee, hand, and shoulder.

Protocol: 4–5x per week
Duration: Over 26 weeks or until symptoms subside

2. Nerve & Neuropathy

Clinical Context: Clinical research maintains there are two approaches to treating Neuropathy—one being high frequencies with sinusoidal alternating current with constant middle frequencies and the second being low therapeutically ranged frequencies.

• High Frequency with Middle Frequency attributes has been found in clinical and animal studies to enhance myelinated axon growth, accelerate nerve fiber maturation, and in some protocols, provide nerve conduction block for pain relief.
• Low Frequencies tends to promote endogenous opioid release and support regenerative cellular processes that aid in nerve regeneration.

Using proprietary settings—delivering a mix between high frequency and low frequency coupled with waveforms specific to treating one’s extremities—the NerveWave delivers therapeutic outcomes. These frequencies and waveforms have been found to stimulate both bioelectrical (low frequency) and biochemical (high frequency) processes in the body at the same time.

Protocol: 6x per week (60–90 uses)

• Primary Phase: 3x/week
• Secondary Phase: 3x/week

Maintenance Phase:

Protocol: 2–5x/week
Duration: 60–90 uses and revisit annually

3. Restorative Recovery

• Delivers gentle, non-fatiguing muscle contractions—primarily targeting small, slow-twitch muscle fibers and lymphatic movement within the muscle—accelerating the recovery process without causing additional strain or muscle fatigue.
• Increases vasodilation while boosting microcirculation and promoting angiogenesis in injured tissue, thus increasing healing.
• Low Frequency promotes lymphatic drainage, reduction of swelling and inflammation, and increasing healing within the muscle and tissue.
• High Frequency addresses post-surgical or post-injury pain syndromes by reducing reliance on pain medication, while increasing range of motion and strength during the rehab phase.

Protocol: 4–5x per week
Duration: Over the course of 13–20 weeks

4. Vagus Nerve Stimulation

• Mild electrical impulses are delivered to the outer ear innervated by the auricular branch of the vagus nerve (ABVN), such as the tragus or cymba concha. This stimulation activates afferent nerve fibers that project to the brainstem, especially the nucleus tractus solitarius (NTS), and in turn modulate central autonomic activity, neurotransmitter release, and the balance of the sympathetic-parasympathetic nervous system.
• Parasympathetic Activation: taVNS increases parasympathetic outflow and reduces sympathetic activity, with clinical studies showing benefits ranging from reduced heart rate and inflammation to enhanced relaxation responses and improved autonomic balance, helping to regulate mood, control inflammation, and modulate involuntary bodily functions like heart rate and digestion.

Protocol: 1–2x daily as needed (10min sessions)
Duration: Vagus Nerve Reset 4-6-weeks.Maintenance 2-4x/week